ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

BHVN Biohaven Ltd

36.96
0.54 (1.48%)
Last Updated: 20:27:04
Delayed by 15 minutes

Biohaven Financial Summary

The current BHVN market cap is 3.74B. The company's latest EPS is USD -4.0364 and P/E is -8.98.

Quarter End
USD (US$)USD (US$)
Total Revenue
Operating Income
Net Income
Year End 31 December 2023 20222023
USD (US$)USD (US$)
Total Revenue 00
Operating Income -567.93M-436.05M
Net Income -570.28M-408.17M
Quarter End
USD (US$)USD (US$)
Total Assets
Total Liabilities
Total Equity
Year End 31 December 2023 20222023
USD (US$)USD (US$)
Total Assets 661.78M513.21M
Total Liabilities 123.01M85.24M
Total Equity 538.77M427.98M
Quarter End
USD (US$)USD (US$)
Operating
Investing
Financing
Year End 31 December 2023 20222023
USD (US$)USD (US$)
Operating -297.69M-331.73M
Investing -304.79M129.83M
Financing 767.6M211.91M
Market Cap 3.74B
Price to Earnings Ratio -8.98
Price to Sales Ratio 0
Price to Cash Ratio 14.75
Price to Book Ratio 8.56
Dividend Yield -

Share Statistics

Shares Outstanding 101.12M
Average Volume (1 week) 1.3M
Average Volume (1 Month) 1.04M
52 Week Change -14.64%
52 Week High 62.21
52 Week Low 26.80
Spread (Intraday) 0.05 (0.14%)

Company Info

Company Name Biohaven Ltd
Address p.o. box 173
road town, tortola
Website https://www.biohavenpharma.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock